Login / Signup

Nigrostriatal dopamine transporter availability in early Parkinson's disease.

Patrik FazioPer SvenningssonZsolt CselényiChrister HalldinLars FardeAndrea Varrone
Published in: Movement disorders : official journal of the Movement Disorder Society (2018)
This is the first study that examines dopamine transporter protein availability in vivo within the entire nigro-striatal pathway. The results suggest that at early stages of symptomatic PD a greater loss is observed at the level of the axonal terminals when compared with cell bodies and axons of dopaminergic neurons. The findings suggest a relative preservation of cell bodies in early PD, which might be relevant for novel disease-modifying strategies. © 2018 International Parkinson and Movement Disorder Society.
Keyphrases
  • single cell
  • cell therapy
  • spinal cord injury
  • uric acid
  • spinal cord
  • stem cells
  • parkinson disease
  • mesenchymal stem cells
  • bone marrow
  • binding protein
  • optical coherence tomography
  • prefrontal cortex
  • protein protein